InspireMD Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
29,258.00
25,095.00
15,585.00
8,461.00
8,438.00
7,240
Depreciation, Depletion & Amortization
208.00
263.00
241.00
191.00
178.00
152
Other Funds
27.00
115.00
113.00
14.00
10.00
336
Funds from Operations
10,656.00
20,285.00
11,376.00
7,205.00
8,071.00
7,424
Changes in Working Capital
356.00
923.00
220.00
290.00
60.00
182
Net Operating Cash Flow
10,300.00
19,362.00
11,596.00
7,495.00
8,131.00
7,606
Capital Expenditures
202.00
133.00
16.00
49.00
258.00
Net Investing Cash Flow
376.00
86.00
23.00
70.00
318.00
Issuance/Reduction of Debt, Net
8,787.00
1,148.00
3,702.00
2,648.00
2,179.00
Net Financing Cash Flow
15,123.00
8,272.00
8,617.00
11,703.00
4,633.00
Net Change in Cash
4,536.00
11,235.00
3,043.00
4,259.00
3,806.00
Free Cash Flow
10,502.00
19,495.00
11,612.00
7,544.00
8,389.00
Other Sources
-
-
-
119.00
-
Change in Capital Stock
23,937.00
9,535.00
12,432.00
14,365.00
6,822.00
Exchange Rate Effect
89.00
59.00
41.00
19.00
10.00
Other Uses
174.00
47.00
7.00
-
60.00

About InspireMD

View Profile
Address
4 Menorat Hamaor Street
Tel Aviv TA 67448
Israel
Employees -
Website http://www.inspiremd.com
Updated 07/08/2019
InspireMD, Inc. is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.